Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D.

CONTEXT Cost-related medication nonadherence (CRN) has been a persistent problem for individuals who are elderly and disabled in the United States. The impact of Medicare prescription drug coverage (Part D) on CRN is unknown. OBJECTIVE To estimate changes in CRN and forgoing basic needs to pay for drugs following Part D implementation. DESIGN, SETTING, AND PARTICIPANTS In a population-level study design, changes in study outcomes between 2005 and 2006 before and after Medicare Part D implementation were compared with historical changes between 2004 and 2005. The community-dwelling sample of the nationally representative Medicare Current Beneficiary Survey (unweighted unique n = 24,234; response rate, 72.3%) was used, and logistic regression analyses were controlled for demographic characteristics, health status, and historical trends. MAIN OUTCOME MEASURES Self-reports of CRN (skipping or reducing doses, not obtaining prescriptions) and spending less on basic needs to afford medicines. RESULTS The unadjusted, weighted prevalence of CRN was 15.2% in 2004, 14.1% in 2005, and 11.5% after Part D implementation in 2006. The prevalence of spending less on basic needs was 10.6% in 2004, 11.1% in 2005, and 7.6% in 2006. Adjusted analyses comparing 2006 with 2005 and controlling for historical changes (2005 vs 2004) demonstrated significant decreases in the odds of CRN (ratio of odds ratios [ORs], 0.85; 95% confidence interval [CI], 0.74-0.98; P = .03) and spending less on basic needs (ratio of ORs, 0.59; 95% CI, 0.48-0.72; P < .001). No significant changes in CRN were observed among beneficiaries with fair to poor health (ratio of ORs, 1.00; 95% CI, 0.82-1.21; P = .97), despite high baseline CRN prevalence for this group (22.2% in 2005) and significant decreases among beneficiaries with good to excellent health (ratio of ORs, 0.77; 95% CI, 0.63-0.95; P = .02). However, significant reductions in spending less on basic needs were observed in both groups (fair to poor health: ratio of ORs, 0.60; 95% CI, 0.47-0.75; P < .001; and good to excellent health: ratio of ORs, 0.57; 95% CI, 0.44-0.75; P < .001). CONCLUSIONS In this survey population, there was evidence for a small but significant overall decrease in CRN and forgoing basic needs following Part D implementation. However, no net decrease in CRN after Part D was observed among the sickest beneficiaries, who continued to experience higher rates of CRN.

[1]  J. Dipiro,et al.  Pharmaceutical manufacturer assistance programs. , 2002, Archives of internal medicine.

[2]  J. Doshi,et al.  Medicare beneficiaries and the impact of gaining prescription drug coverage on inpatient and physician spending. , 2005, Health services research.

[3]  S. Soumerai,et al.  The case for a medicare drug coverage benefit: a critical review of the empirical evidence. , 2001, Annual review of public health.

[4]  L. Fried,et al.  Diagnosis of Illness Presentation in the Elderly , 1991, Journal of the American Geriatrics Society.

[5]  S. Crystal,et al.  Out-of-pocket health care costs among older Americans. , 2000, The journals of gerontology. Series B, Psychological sciences and social sciences.

[6]  D. McFadden,et al.  Who failed to enroll in Medicare Part D, and why? Early results. , 2006, Health affairs.

[7]  N. Lurie,et al.  The prevalence and effects of hunger in an emergency department patient population. , 1999, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[8]  B. Stuart,et al.  Assessing the impact of coverage gaps in the Medicare Part D drug benefit. , 2005, Health affairs.

[9]  J. Kasper,et al.  Uncovering the health challenges facing people with disabilities: the role of health insurance. , 2003, Health Affairs.

[10]  K. Langa,et al.  The Health Effects of Restricting Prescription Medication Use Because of Cost , 2004, Medical care.

[11]  Sydney Katz.  Assessing Self‐maintenance: Activities of Daily Living, Mobility, and Instrumental Activities of Daily Living , 1983, Journal of the American Geriatrics Society.

[12]  B. Stuart,et al.  Prescription drug costs for Medicare beneficiaries: coverage and health status matter. , 2000, Issue brief.

[13]  J. Gurwitz,et al.  Patients At-Risk for Cost-Related Medication Nonadherence: A Review of the Literature , 2007, Journal of General Internal Medicine.

[14]  J. Zhang,et al.  What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. , 1998, JAMA.

[15]  J. Poisal,et al.  Medicare beneficiaries and drug coverage. , 2000, Health affairs.

[16]  J. Poisal.  Reporting of Drug Expenditures in the MCBS , 2003, Health care financing review.

[17]  S B Soumerai,et al.  Use of antihypertensive drugs by Medicare enrollees: does type of drug coverage matter? , 2001, Health affairs.

[18]  S. Soumerai.  Benefits and risks of increasing restrictions on access to costly drugs in Medicaid. , 2004, Health affairs.

[19]  C. Thomas,et al.  How do seniors use their prescription drug discount cards? , 2005, Health affairs.

[20]  M. Laschober,et al.  Trends in Medicare supplemental insurance and prescription drug coverage, 1996-1999. , 2002, Health affairs.

[21]  J. Blustein,et al.  Drug coverage and drug purchases by Medicare beneficiaries with hypertension. , 2000, Health affairs.

[22]  S. Soumerai,et al.  Inadequate Prescription-Drug Coverage for Medicare Enrollees — A Call to Action , 2017 .

[23]  J. Gurwitz,et al.  Reliability of New Measures of Cost-Related Medication Nonadherence , 2008, Medical care.

[24]  J Z Ayanian,et al.  Supplemental insurance and use of effective cardiovascular drugs among elderly medicare beneficiaries with coronary heart disease. , 2001, JAMA.

[25]  J. Gurwitz,et al.  Cost-related medication nonadherence among elderly and disabled medicare beneficiaries: a national survey 1 year before the medicare drug benefit. , 2006, Archives of internal medicine.

[26]  A. Robbins,et al.  What's the relative risk? A method to directly estimate risk ratios in cohort studies of common outcomes. , 2002, Annals of epidemiology.

[27]  D. Crippen.  Projections of medicare and prescription drug spending , 2002 .

[28]  A. Rodday,et al.  Medicare prescription drug benefit progress report: findings from a 2006 national survey of seniors. , 2007, Health affairs.

[29]  I. Wilson,et al.  Prescription drug coverage and seniors: how well are states closing the gap? , 2002, Health affairs.

[30]  B. Stuart,et al.  Dynamics in drug coverage of Medicare beneficiaries: finders, losers, switchers. , 2001, Health affairs.

[31]  B. Stuart,et al.  Medicare's Disabled Beneficiaries: The Forgotten Population in the Debate Over Drug Benefits , 2002 .

[32]  N. Schoenberg,et al.  Burden of common multiple-morbidity constellations on out-of-pocket medical expenditures among older adults. , 2007, The Gerontologist.

[33]  C. Cowan,et al.  National health spending in 2004: recent slowdown led by prescription drug spending. , 2006, Health affairs.

[34]  Carl-Erik Särndal,et al.  Model Assisted Survey Sampling , 1997 .

[35]  I. Wilson,et al.  Prescription drug coverage and seniors: findings from a 2003 national survey. , 2005, Health affairs.

[36]  N. Lurie,et al.  Hunger in an adult patient population. , 1998, JAMA.

[37]  Karen B DeSalvo,et al.  Predicting mortality and healthcare utilization with a single question. , 2001, Health services research.

[38]  D. Weir,et al.  Take-Up of Medicare Part D and the SSA Subsidy: Early Results from the Health and Retirement Study , 2007 .

[39]  P. Cleary,et al.  Illness Behavior in the Aged , 1988, Journal of the American Geriatrics Society.

[40]  M. C. Jaklevic.  Kaiser Family Foundation to sell bonds. , 2001, Modern healthcare.